0001836562-20-000001.txt : 20201221 0001836562-20-000001.hdr.sgml : 20201221 20201221170255 ACCESSION NUMBER: 0001836562-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201221 DATE AS OF CHANGE: 20201221 EFFECTIVENESS DATE: 20201221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hopewell Therapeutics, Inc. CENTRAL INDEX KEY: 0001836562 IRS NUMBER: 823045662 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383915 FILM NUMBER: 201404948 BUSINESS ADDRESS: STREET 1: 405 WALTHAM STREET CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617 921 7082 MAIL ADDRESS: STREET 1: 405 WALTHAM STREET CITY: LEXINGTON STATE: MA ZIP: 02421 D 1 primary_doc.xml X0708 D LIVE 0001836562 Hopewell Therapeutics, Inc. 405 WALTHAM STREET LEXINGTON MA MASSACHUSETTS 02421 617 921 7082 MASSACHUSETTS None None Corporation true 2018 Qiaobing Xu 405 Waltham Street, Suite 418 Lexington MA MASSACHUSETTS 02421 Executive Officer Director Biotechnology Decline to Disclose 06b false 2020-12-07 false true true false 0 500000 500000 0 false 1 0 0 0 false Hopewell Therapeutics, Inc. Qiaobing Xu Qiaobing Xu Chief Executive Officer 2020-12-21